Peer-reviewed articles, consensus statements, procedure cards and indexed conference abstracts in surgical oncology — from peritoneal surface malignancy and PIPAC to robotic, breast and gynaecological cancer surgery.
16+
Years of experience
11,000+
Cancer surgeries / procedures
80+
Scientific publications
7
International fellowships
Peritoneal surface malignancy
HIPEC, PIPAC & cytoreductive surgery
Clinical studies, national surveys and consensus statements on CRS-HIPEC, PIPAC, ERAS and peritoneal metastases — including several first-in-India reports.
01
Safety Profile of PIPAC in Patients Receiving Uninterrupted Bevacizumab-based Systemic Chemotherapy: A Retrospective Analysis from a High-volume Tertiary Centre
Surgical Oncology Insight · 2026;3
02
Perioperative Safety and Tolerability of PIPAC with Concurrent Systemic Therapy During the Same Admission as Bidirectional Chemotherapy
PIPAC Versus Intravenous Chemotherapy in Unresectable Peritoneal Metastases Secondary to Platinum-resistant Ovarian Cancer: Interim Analysis of a Randomized Controlled Trial
Bidirectional Chemotherapy with PIPAC and Intravenous Chemotherapy in Advanced Primary Epithelial Ovarian Cancer: A New Way to Travel the Old Roads
International Journal of Gynecological Cancer · 2025;35(2):100354
08
Indocyanine Green for Assessing Bowel Perfusion During Cytoreductive Surgery with HIPEC
International Journal of Gynecological Cancer · 2025;35(2):100956
09
Evaluating Dose Intensification of PIPAC in Recurrent Platinum-resistant Ovarian Cancer with Peritoneal Involvement: A Single-centre Randomised Controlled Trial
International Journal of Gynecological Cancer · 2025;35(2):101184
10
Fluorescence-guided Total Robotic Parietal Peritonectomy, Cytoreductive Surgery and Closed HIPEC
CRS-HIPEC Following Neoadjuvant PIPAC with Systemic Chemotherapy in Primarily Advanced Inoperable Epithelial Ovarian Cancer: An ISPSM Collaborative Study
Delay in Time to Adjuvant Chemotherapy and Its Impact on Outcomes in Completely Resected Advanced Ovarian Malignancies Treated with CRS, CRS-IP and CRS-HIPEC
Comparison of Outcomes Following Complete and Selective Parietal Peritonectomy During CRS-HIPEC for Advanced Epithelial Ovarian Cancer: An ISPSM Study
Indian Journal of Gynecologic Oncology · 2018
27
Standardization of Patient Selection and HIPEC Protocol for Peritoneal Surface Malignancy in Indian Patients
Indian Journal of Gynecologic Oncology · 2017
28
Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer: Single-Centre Experience
Indian Journal of Surgical Oncology · 2012
29
Impact of Surgical Complexity on Clinical Outcomes in Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer: A Tertiary-centre Study
Robotic & minimally invasive surgery
Robotic cancer surgery
Randomised and prospective studies, learning-curve analyses and experience-based procedure cards for robotic colorectal, gynaecological, thyroid and oesophageal surgery — including tele-robotic surgery across 2,100 km.
01
Prospective Analysis of Autonomic Nerve-preserving Robotic Rectal Cancer Surgery Using the SSI Mantra Robot
Robotic-Assisted Pelvic and High Para-aortic Lymphadenectomy for Endometrial Cancer and the Learning Curve
Indian Journal of Gynecologic Oncology · 2016
15
Prospective Randomized Study Comparing Robotic-Assisted Surgery with Traditional Laparotomy for Rectal Cancer: An Indian Study
Indian Journal of Surgery · 2013
Breast cancer
Breast oncology & sentinel node research
Sentinel lymph node biopsy with ICG fluorescence, recurrence analyses, neoadjuvant response and intraoperative radiotherapy in early breast cancer.
01
IOERT as a Tumour-bed Boost in Early Breast Cancer Patients Undergoing Breast-conserving Surgery: Feasibility and Surgical Aspects
European Journal of Surgical Oncology · Vol. 52
02
Psychological Analysis of Breast Cancer Patients Undergoing Modified Radical Mastectomy and Breast Conservation Surgery and Its Impact on Objectified Body Consciousness
ICG Instillation in the Inguinal Node Versus Foot Web Space for Identification of the Thoracic Duct During Robotic-assisted Transthoracic Oesophagectomy
Early Tumour Shrinkage and Depth of Response as Predictors of Favourable Outcomes in Metastatic Colorectal Cancer Treated with FOLFOX/FOLFIRI Plus Cetuximab
Reviews on Recent Clinical Trials · 2015;10(4):302-308
08
Assessment of Tumour Response and Resection Rates in Unresectable Colorectal Liver Metastases Following Neoadjuvant Chemotherapy with Cetuximab
Indian Journal of Surgical Oncology · 2014
Compiled from Dr Ashwin K R’s curriculum vitae and publication records. DOI links open the publisher’s record; a few entries await complete bibliographic details.
Researcher, fellow or referring clinician?
Reach out for academic collaboration, second opinions or complex case referrals.
